Longer follow-up continues to reveal no increased risk of cancer with the use of recombinant human bone morphogenetic protein in spine fusion

Joseph R. Dettori, Jens R. Chapman, John Glenden DeVine, Robert A. McGuire, Mark R. Junge, Daniel C. Norvell

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Longer follow-up continues to reveal no increased risk of cancer with the use of recombinant human bone morphogenetic protein in spine fusion'. Together they form a unique fingerprint.

Medicine & Life Sciences